These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34260563)

  • 1. Self-efficacy remains a vital factor in reducing the risk of dialysis in type 2 diabetes care.
    Liao K; Lin KC; Chiou SJ
    Medicine (Baltimore); 2021 Jul; 100(28):e26644. PubMed ID: 34260563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.
    Chiou SJ; Liao K; Huang YT; Lin W; Hsieh CJ
    J Diabetes Investig; 2021 May; 12(5):819-827. PubMed ID: 33025682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
    Chen CC; Cheng SH
    Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.
    Jang YJ; Choy YS; Nam CM; Moon KT; Park EC
    BMC Nephrol; 2018 Jun; 19(1):127. PubMed ID: 29871604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
    Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
    Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
    Yu HC; Tsai WC; Kung PT
    Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage.
    Liao PJ; Lin TY; Wang TC; Ting MK; Wu IW; Huang HT; Wang FC; Chang HC; Hsu KH
    Medicine (Baltimore); 2016 Apr; 95(14):e3282. PubMed ID: 27057892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
    Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
    J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions?
    Huang YC; Lee MC; Chou YJ; Huang N
    Med Care; 2016 Nov; 54(11):977-983. PubMed ID: 27547944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study.
    Hu HY; Jian FX; Lai YJ; Yen YF; Huang N; Hwang SJ
    BMJ Open; 2019 Sep; 9(9):e031354. PubMed ID: 31519682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pay-for-performance program on infection events and mortality rate in diabetic patients: a nationwide population-based cohort study.
    Wu YF; Chen MY; Chen TH; Wang PC; Peng YS; Lin MS
    BMC Health Serv Res; 2021 Jan; 21(1):78. PubMed ID: 33478477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus.
    Kung FP; Tsai CF; Lu CL; Huang LC; Lu CH
    Medicine (Baltimore); 2020 Feb; 99(7):e19139. PubMed ID: 32049836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pay-for-performance and continuity of care synergistically reduced amputation of lower extremity in patients with diabetes: a population-based cohort study.
    Chen YC; Liao YH; Ku LE; Wang JD
    BMC Health Serv Res; 2022 Jun; 22(1):748. PubMed ID: 35659668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pay-for-Performance for Primary Care Physicians on Preventable Diabetes-Related Hospitalization Costs Among Adults in New Brunswick, Canada: A Quasiexperimental Evaluation.
    Gupta N; Lavallée R; Ayles J
    Can J Diabetes; 2019 Jul; 43(5):354-360.e1. PubMed ID: 30679059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
    Chou CW; Kung PT; Chou WY; Tsai WC
    BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
    Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
    Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.
    Chen YC; Lee CT; Lin BJ; Chang YY; Shi HY
    Medicine (Baltimore); 2016 Jul; 95(27):e4197. PubMed ID: 27399144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient assessment of diabetes care in a pay-for-performance program.
    Chiu HC; Hsieh HM; Lin YC; Kuo SJ; Kao HY; Yeh SC; Chang WH; Hsiao PJ; Chen YS; Lin SL; Lo GH; Ker CG; Hung YH; Cheng HA; Chou TH; Chou SY; Wang JH; Wang CF
    Int J Qual Health Care; 2016 Apr; 28(2):183-90. PubMed ID: 26819445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
    Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
    Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.